This content is machine translated Type 2 diabetes mellitus Heart and kidney protected in different patient groups Approximately 40% of patients with type 2 diabetes mellitus (T2DM) develop diabetic kidney disease, which contributes to increased cardiovascular and mortality risk [1, 2]. This makes it all the more…
View Post 3 min This content is machine translated Type 1 diabetes Despite known cardiac risk, many patients are undertreated Cardiac problems such as coronary artery disease and heart failure are among the most common and dangerous complications of type 1 diabetes. The mortality risk is significantly increased. Although this…
View Post 4 min This content is machine translated Diabetes Cases Type 2 diabetes mellitus and marked obesity A 48-year-old, severely obese patient is diagnosed with full-blown metabolic syndrome during an operative evaluation of osteoarthritis of the upper ankle. His arterial hypertension, dyslipidemia, hyperuricemia, grade III obesity, and…
View Post 7 min This content is machine translated Diabetes Management Nephro- and cardioprotection as an interdisciplinary challenge Early detection and treatment of renal dysfunction and cardiovascular risk factors in type 2 diabetes mellitus is essential. Experts see a need for action in this area, especially with regard…
View Post 6 min This content is machine translated Sponsored Content Rybelsus® – Semaglutide as the world’s first and only oral GLP-1 analogue People with type 2 diabetes have too little endogenous GLP-1 (glucagon-like peptide 1) or its effect is reduced. Semaglutide, mimicking natural GLP-1, can compensate for this.1 It lowers blood glucose,…
View Post 1 min This content is machine translated Diabetes Cases Long-standing diabetic patient at high cardiovascular risk. A 65-year-old female patient with long-standing diabetes, hypertension, and hyperlipidemia comes to a new practice because of her primary care physician’s retirement. How should the new attending physician proceed? What…
View Post 3 min This content is machine translated Diabetes Therapy Do GLP-1 receptor agonists contribute to stroke prophylaxis? The risk of suffering a stroke is massively higher for diabetics than in the general population. New data suggest that dulaglutide reduces the risk of ischemic stroke in diabetic patients…
View Post 4 min This content is machine translated Diabetes mellitus type 2 New Swiss guidelines support cardiovascular disease control The treatment of type 2 diabetes mellitus has undergone a transformation in recent years with the approval of new drug classes. The focus is no longer on pure glycemic control,…
View Post 3 min This content is machine translated Diabetic kidney disease Canagliflozin approved in fast track for diabetic nephropathy Kidney protection is extremely important for diabetes sufferers. Recently, canagliflozin became the first SGLT-2 inhibitor in Switzerland to receive a marketing authorization extension to reduce the risk of progression to…
View Post 3 min This content is machine translated Heart failure in type 2 diabetes Indication expansion for SGLT2 inhibitor and combination preparation Because of the high prevalence and mortality, it is particularly important to protect patients with type 2 diabetes from heart failure as early as possible. The indication expansion of dapagliflozin…
View Post 3 min This content is machine translated Chronic renal failure Dapagliflozin meets primary endpoints ahead of schedule The Phase III DAPA-CKD study will be terminated earlier than planned due to proven efficacy in patients with chronic renal failure. Dapagliflozin is the first SGLT2 inhibitor to show meaningful…
